Literature DB >> 17869162

TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin.

Devipriya Subramaniyam1, Robert Virtala, Krzysztof Pawłowski, Ib Groth Clausen, S Warkentin, Tim Stevens, Sabina Janciauskiene.   

Abstract

Endothelial cells are among the main physiological targets of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). In endothelial cells TNF-alpha elicits a broad spectrum of biological effects including differentiation, proliferation and apoptosis. alpha1-antitrypsin (AAT), an endogenous inhibitor of serine proteases plays a vital role in protecting host tissue from proteolytic injury at sites of inflammation. Recently, it has been shown that AAT can be internalized by pulmonary endothelial cells, raising speculation that it may modulate endothelial cell function in addition to suppressing protease activity. Using Affymetrix microarray technology, real time PCR and ELISA methods we have investigated the effects of AAT on un-stimulated and TNF-alpha stimulated human primary lung microvascular endothelial cell gene expression and protein secretion. We find that AAT and TNF-alpha generally induced expression of distinct gene families with AAT exhibiting little activity in terms of inflammatory gene expression. Approximately 25% of genes up regulated by TNF-alpha were inhibited by co-administration of AAT including TNF-alpha-induced self expression. Surprisingly, the effects of AAT on TNF-alpha-induced self expression was inhibited equally well by oxidized AAT, a modified form of AAT, which lacks serine protease inhibitor activity. Overall, the pattern of gene expression regulated by native and oxidized AAT was similar with neither inducing pro-inflammatory gene expression. These findings suggest that inhibitory effects of native and oxidized forms of AAT on TNF-alpha stimulated gene expression may play an important role in limiting the uncontrolled endothelial cell activation and vascular injury in inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869162     DOI: 10.1016/j.biocel.2007.07.016

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 2.  Lung disease associated with alpha1-antitrypsin deficiency.

Authors:  Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Proc Am Thorac Soc       Date:  2010-11

Review 3.  Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?

Authors:  Diana Crossley; Robert Stockley; Elizabeth Sapey
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

4.  The multiple facets of alpha-1-antitrypsin.

Authors:  Robert A Stockley
Journal:  Ann Transl Med       Date:  2015-06

5.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

6.  Dysregulated relationship of inflammation and oxidative stress in major depression.

Authors:  B J Rawdin; S H Mellon; F S Dhabhar; E S Epel; E Puterman; Y Su; H M Burke; V I Reus; R Rosser; S P Hamilton; J C Nelson; O M Wolkowitz
Journal:  Brain Behav Immun       Date:  2012-11-29       Impact factor: 7.217

7.  Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium.

Authors:  Sadaf Sohrab; Daniela N Petrusca; Angelia D Lockett; Kelly S Schweitzer; Natalia I Rush; Yuan Gu; Krzysztof Kamocki; Jana Garrison; Irina Petrache
Journal:  FASEB J       Date:  2009-05-07       Impact factor: 5.191

8.  Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.

Authors:  Siyoung Lee; Youngmin Lee; Kwangwon Hong; Jaewoo Hong; Suyoung Bae; Jida Choi; Hyunjhung Jhun; Areum Kwak; Eunsom Kim; Seunghyun Jo; Charles A Dinarello; Soohyun Kim
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

9.  Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.

Authors:  Yi He; Graziella E Ronsein; Chongren Tang; Gail P Jarvik; W Sean Davidson; Vishal Kothari; Hyun D Song; Jere P Segrest; Karin E Bornfeldt; Jay W Heinecke
Journal:  Circ Res       Date:  2020-08-21       Impact factor: 17.367

10.  Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.

Authors:  Irina Petrache; Joud Hajjar; Michael Campos
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.